Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1

NCT04125472 · clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alnylam Pharmaceuticals